Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.
Behr TM, Liersch T, Greiner-Bechert L, Griesinger F, Béhé M, Markus PM, Gratz S, Angerstein C, Brittinger G, Becker H, Goldenberg DM, Becker W. Behr TM, et al. Cancer. 2002 Feb 15;94(4 Suppl):1373-81. doi: 10.1002/cncr.10308. Cancer. 2002. PMID: 11877768 Free article. Clinical Trial.
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.
Liersch T, Meller J, Kulle B, Behr TM, Markus P, Langer C, Ghadimi BM, Wegener WA, Kovacs J, Horak ID, Becker H, Goldenberg DM. Liersch T, et al. Among authors: behr tm. J Clin Oncol. 2005 Sep 20;23(27):6763-70. doi: 10.1200/JCO.2005.18.622. J Clin Oncol. 2005. PMID: 16170184 Clinical Trial.
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM, Gratz S, Markus PM, Dunn RM, Hüfner M, Schauer A, Fischer M, Munz DL, Becker H, Becker W. Behr TM, et al. Cancer. 1997 Dec 15;80(12 Suppl):2436-57. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2436::aid-cncr16>3.3.co;2-3. Cancer. 1997. PMID: 9406695
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W. Behr TM, et al. Int J Cancer. 1998 May 29;76(5):738-48. doi: 10.1002/(sici)1097-0215(19980529)76:5<738::aid-ijc20>3.0.co;2-z. Int J Cancer. 1998. PMID: 9610734 Free article.
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
Behr TM, Memtsoudis S, Sharkey RM, Blumenthal RD, Dunn RM, Gratz S, Wieland E, Nebendahl K, Schmidberger H, Goldenberg DM, Becker W. Behr TM, et al. Int J Cancer. 1998 Aug 31;77(5):787-95. doi: 10.1002/(sici)1097-0215(19980831)77:5<787::aid-ijc19>3.0.co;2-z. Int J Cancer. 1998. PMID: 9688314 Free article.
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W. Behr TM, et al. Cancer Res. 1999 Jun 1;59(11):2635-43. Cancer Res. 1999. PMID: 10363986
155 results